Targeting high-risk patients with single-pill combination therapies, also known as polypills, could change healthcare on a global scale, according new data published in the Journal of the American College of Cardiology. 

Allen Taylor, MD, thinks AI-powered plaque evaluations can make a substantial impact on patient care. 

When older patients undergo SAVR with concomitant procedures, it increases their short- and long-term risks of mortality. Should this influence care teams to consider more transcatheter treatments? 

The company's automated insulin pump can now be used to treat more patients thanks to an expanded CE mark approval. Could updates from the FDA be next?

Women are associated with a significantly higher rate of in-hospital disabling strokes than men, according to a new study of nearly 380,000 TAVR patients. What can cardiologists do to help limit these complications? 

Toby Rogers, MD, PhD, noted that BASILICA is a fairly complex procedure. Using this advanced technology, however, could make it easier to perform and improve patient access.

The FDA thinks 24/7 fitness trackers from Boston-based Whoop should be regulated like medical devices. Whoop disagrees, however, and neither side appears to be changing its mind. 

When doctors are accused of mishandling the heart health of a young athlete, it occasionally ends up being settled in a courtroom. 

The Heart Rhythm Society and its new advocacy arm plan on pushing CMS to include certain policy improvements in the 2026 MPFS.

Care teams should be aware of this difference, even using CT images when possible to look for signs of any potential issues.

Gen Xers and their elders tend to believe AI will do more harm than good. More than half of American adults 50 and older place themselves in that somewhat cynical category. 

A new poll from YouGov measuring sentiment around President Donald Trump’s policies and the “Big, Beautiful Bill Act” found that the public fears healthcare costs are about to rise.